孟德尔随机化
免疫系统
肺癌
免疫学
生物
抗体
医学
转录组
等离子体电池
癌症研究
细胞
癌症
孟德尔遗传
肺
全基因组关联研究
T细胞
免疫疗法
免疫原性
肺癌易感性
遗传学
肿瘤科
生物信息学
基因
作者
Ling Wu,冯慧晶,柴立勋,Xiaofeng Luo,Chenhui Zhao,Yunfei Wang
标识
DOI:10.1177/03000605261506563
摘要
ObjectiveTo investigate the potential causal relationships between circulating plasma proteins and non-small cell lung cancer and to assess whether antibody immune response traits mediate these associations.MethodsWe conducted an integrative genetic epidemiology study combining two-sample Mendelian randomization, mediation analysis, single-cell transcriptomics, and tissue-based experimental validation. Plasma protein data for 4907 proteins and genome-wide association study summary statistics for 46 antibody immune response traits were analyzed alongside non-small cell lung cancer genome-wide association study data from 218,792 individuals of European ancestry (1627 cases and 217,165 controls). Five complementary Mendelian randomization methods were applied; sensitivity analyses assessed heterogeneity, horizontal pleiotropy, and robustness, and reverse Mendelian randomization assessed potential reverse causation. Mediation analysis evaluated antibody immune response traits as candidate intermediate phenotypes. Prioritized proteins were further characterized using single-cell RNA sequencing data and paired tumor and adjacent normal tissues from patients with histopathologically confirmed non-small cell lung cancer.ResultsWe identified 1188 plasma proteins with potential causal associations with non-small cell lung cancer risk. CLEC10A and TGM3 were prioritized through sequential plasma protein-non-small cell lung cancer, plasma protein-antibody immune response, and mediation analyses. Higher genetically predicted CLEC10A levels were associated with increased non-small cell lung cancer risk, whereas higher genetically predicted TGM3 levels were associated with lower non-small cell lung cancer risk. Five antibody immune response traits were initially associated with non-small cell lung cancer, of which four were retained after robustness assessment. Mediation analysis identified three candidate plasma protein-antibody immune response-non-small cell lung cancer pathways involving GCST90006921 and GCST90006923. Single-cell analysis localized CLEC10A and TGM3 predominantly to macrophages, while paired tissue analyses showed higher CLEC10A and lower TGM3 expression in tumors.ConclusionsCLEC10A and TGM3 may contribute to non-small cell lung cancer susceptibility, with specific antibody immune response traits representing candidate intermediate immune pathways. These findings provide genetic and complementary biological support for further independent replication and mechanistic investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI